Scientists create detailed brain maps to protect language during surgery

NCT ID NCT05989893

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This study aims to map the brain regions essential for language and cognition in people with epilepsy or brain tumors. Participants perform language-based tasks while their brain activity is recorded using fMRI or electrical stimulation. The goal is to compare brain organization between healthy individuals and patients, and to create spatial probability maps that can guide surgeons to avoid critical language areas during operations.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
language-based tasks (behavioral intervention)
What this could lead to
If successful, this could create detailed brain maps that help surgeons avoid damaging essential language areas during epilepsy or tumor surgery.
What could go wrong
This is an observational mapping study, not a treatment trial. Results may not apply to everyone, and individual brain organization varies widely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRAIN TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The University of Texas Health Science Center at Houston

    RECRUITING

    Houston, Texas, 77479, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.